Exploiting Nutrition on Delay Cataract

利用营养来延缓白内障的发生

基本信息

  • 批准号:
    6998424
  • 负责人:
  • 金额:
    $ 15.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-01-01 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cataract, or opacification of the lens, is a major cause of visual disability. Cataract extraction is the most frequently performed surgery and costs for cataract-related problems account for the largest line item in the Medicare budget. Delaying cataract by 10 years would halve the number of cataract extractions and save over $1 billion annually. Studies suggest that nutrition may be exploited to diminish the prevalence of or retard the progress of age-related cataract. However, there is little epidemiologic research regarding relations between major components of diet (other than for antioxidants) and risk for prevalence or progress of cataract. This knowledge is important in order to know if people at high risk or with early lens opacities might benefit from proper dietary management. This NEI R03 proposal from the Nutrition and Vision Project (NVP) - a collaboration between Tufts University and the Nurses' Health Study (NHS) at Harvard University and Harvard Medical School - exploits unique existing ophthalmologic and nutritional databases to assess three previously untested hypotheses about the extent to which nutrition affects risk for prevalence and progress of opacification. The NVP ophthalmologic data set includes two sets of graded lens images, gathered five years apart, from 451 women (ages 53-73 y) who are a subset of the NHS. The NHS data set includes long-term nutritional data from 5 food frequency questionnaires and a plethora of data on other personal and environmental factors, all gathered during a 15-year period before the baseline eye exam. Combined, these data will be used to test three hypotheses: that risk for cataract is lower in persons who a) consume higher levels of specific fats (monounsaturated, polyunsaturated, and saturated dietary fats, n-3 fatty acids, etc.), b) consume lower glycemic index foods, and c) eat according to particular dietary patterns.
描述(由申请人提供):白内障或透镜混浊是视力残疾的主要原因。白内障摘除术是最常见的手术,白内障相关问题的费用占医疗保险预算中最大的项目。将白内障手术推迟10年将使白内障摘除手术的数量减少一半,每年可节省10亿美元以上。研究表明,营养可用于减少年龄相关性白内障的患病率或延缓其进展。然而,关于饮食的主要成分(抗氧化剂除外)与白内障患病率或进展风险之间的关系的流行病学研究很少。这些知识对于了解高危人群或早期透镜混浊患者是否能从适当的饮食管理中获益是很重要的。来自营养与视力项目(NVP)的NEI R 03提案-塔夫茨大学与哈佛大学和哈佛医学院的护士健康研究(NHS)之间的合作-利用独特的现有眼科和营养数据库来评估三个以前未经检验的假设,即营养影响浑浊患病率和进展风险的程度。NVP眼科数据集包括两组分级的透镜图像,从451名女性(年龄53-73岁)(NHS的一个子集)中采集,间隔5年。NHS数据集包括来自5份食物频率问卷的长期营养数据以及关于其他个人和环境因素的大量数据,所有这些数据都是在基线眼科检查前的15年期间收集的。结合起来,这些数据将用于测试三个假设:白内障的风险在以下人群中较低:a)消耗较高水平的特定脂肪(单不饱和、多不饱和和饱和膳食脂肪、n-3脂肪酸等),B)食用较低血糖指数食物,和c)根据特定饮食模式进食。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Informing food choices and health outcomes by use of the dietary glycemic index.
  • DOI:
    10.1111/j.1753-4887.2011.00382.x
  • 发表时间:
    2011-04
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Chiu CJ;Liu S;Willett WC;Wolever TM;Brand-Miller JC;Barclay AW;Taylor A
  • 通讯作者:
    Taylor A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLEN TAYLOR其他文献

ALLEN TAYLOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLEN TAYLOR', 18)}}的其他基金

Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    10480733
  • 财政年份:
    2018
  • 资助金额:
    $ 15.97万
  • 项目类别:
Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    9789323
  • 财政年份:
    2018
  • 资助金额:
    $ 15.97万
  • 项目类别:
Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    9989122
  • 财政年份:
    2018
  • 资助金额:
    $ 15.97万
  • 项目类别:
Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    8337706
  • 财政年份:
    2011
  • 资助金额:
    $ 15.97万
  • 项目类别:
Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    8526468
  • 财政年份:
    2011
  • 资助金额:
    $ 15.97万
  • 项目类别:
Mechanistically linking AMD, glycemic index and protein homeostasis
AMD、血糖指数和蛋白质稳态的机制联系
  • 批准号:
    8186942
  • 财政年份:
    2011
  • 资助金额:
    $ 15.97万
  • 项目类别:
Exploiting Nutrition on Delay Cataract
利用营养延缓白内障发生
  • 批准号:
    6875387
  • 财政年份:
    2005
  • 资助金额:
    $ 15.97万
  • 项目类别:
UBIQUITINATION LENS PROLIFERATION/DIFFERENTIATION
泛素化镜片增殖/分化
  • 批准号:
    6226881
  • 财政年份:
    2001
  • 资助金额:
    $ 15.97万
  • 项目类别:
Ubiquitin Function In Eye Lens
眼晶状体中的泛素功能
  • 批准号:
    8045380
  • 财政年份:
    2001
  • 资助金额:
    $ 15.97万
  • 项目类别:
Ubiquitination Lens Proliferation/Differentiation
泛素化透镜增殖/分化
  • 批准号:
    6875442
  • 财政年份:
    2001
  • 资助金额:
    $ 15.97万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.97万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 15.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了